SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-004413
Filing Date
2020-02-12
Accepted
2020-02-12 21:32:05
Documents
1
Period of Report
2020-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3167
  Complete submission text file 0000899243-20-004413.txt   4637
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Issuer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2450 HOLCOME BLVD. SUITE J-608 HOUSTON TX 77021
Business Address
Arthur David J. (Reporting) CIK: 0001769331 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 20606684